Modulating GPR17 has shown the potential to improve inflammatory responses and injury, as evidenced by the suppression of microglial activation and inflammation in an ischemic stroke model [30] and the protection against myocardial fibrosis caused by cardiac ischemia [31]. This evidence concerns the gene GPR17 and Myocardial fibrosis.